US 10087181
Compound as WNT signaling inhibitor, composition, and use thereof
granted A61PA61P1/16A61P11/00
Quick answer
US patent 10087181 (Compound as WNT signaling inhibitor, composition, and use thereof) held by Curegenix, Inc. expires Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Curegenix, Inc.
- Grant date
- Tue Oct 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61P, A61P1/16, A61P11/00, A61P13/12, A61P17/00